Free tools Windows power users keep installed
One-click scans. No signup required.
iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
NIH reported a record 1,648 early-stage investigators (ESIs) receiving R01-equivalent extramural awards in fiscal year 2026 (FY2026)—25% above its ten-year average. That is a clear boost for this group, but it does not establish that NIH made more grants overall. The latest complete-year totals show fewer awards in FY2025; FY2026’s final overall counts were not yet available when NIH announced the ESI result on October 8, 2026.
How many early-career researchers did NIH fund in 2026?
NIH reported 1,648 ESI recipients of R01-equivalent extramural research awards in FY2026, its highest recorded count for this measure. The figure is 25% higher than the ten-year average of 1,323, according to NIH’s October 8, 2026 announcement.
This is a specific measure, not a count of every early-career person or every kind of NIH support. It covers ESI principal investigators receiving R01-equivalent extramural awards. NIH also announced Generation Discovery, a separate effort to recruit 100 early-career principal investigators into its Intramural Research Program over three years. Those recruits would work within NIH’s own research program; they are not part of the extramural award count.
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Repair Windows errors before they cause bigger problemsFix Now →Did NIH make fewer new grants overall?
The answer depends on the fiscal year and what counts as an award. NIH’s completed FY2025 figures show fewer awards than in FY2024. But as of October 8, 2026, final frozen FY2026 figures were not available, so a full-year FY2026 decline in overall or competing awards could not yet be confirmed.
#1 Best Overall
| Measure | FY2025 result compared with FY2024 | What it counts |
|---|---|---|
| Total extramural awards | 55,394 awards, down 6.2% | All extramural awards in NIH’s reported total |
| Competing Research Project Grant (RPG) awards | 8,161 awards, down 20.5%; RPG success rate fell from 18.5% to 13.0% | Competing RPG awards, including new and renewal awards; not all NIH awards |
| ESI R01-equivalent awardees | 1,144 people, down from 1,423 in FY2024; ESI funding rate fell from 26.1% to 18.9% | People-based principal-investigator figures for this award category, not all applications or all early-career support |
NIH published the FY2025 award figures in its March 12, 2026 FY2025 analysis and the career-stage figures in its February 10, 2026 ESI analysis.
A separate, incomplete-year comparison gives a signal about FY2026’s pace, not its final result: AAMC found that by August 31, 2026, NIH had funded 1,924 fewer grants than by the same date in FY2025 and 9,714 fewer than by that date in FY2024. AAMC’s September 9, 2026 snapshot ends on August 31; awards made later in the fiscal year are not included.
Why can awards fall when NIH funding rises?
Award totals and funding dollars measure different things. NIH’s FY2025 total extramural funding was $35.30 billion, up 0.4% from FY2024, despite the 6.2% drop in total award count. For RPGs, competing and noncompeting funding together rose 3.0%, while competing award numbers fell 20.5%; the average RPG size increased 8.9% to $675,426. NIH summarized the pattern as fewer new awards alongside a higher average cost per award.
Recommended Free Tools
Several factors affect how dollars translate into award counts: award size, whether commitments for multiyear projects are funded up front or incrementally, and how funds are allocated. Therefore, neither a higher appropriation nor a higher total funding amount by itself means more grants were made.
NIH reported $47.5 billion in FY2026 program-level funding, 1% above FY2025, in its FY2026 fiscal policy notice. That funding level does not settle the final award count. NIH’s public dashboard described FY2026 figures as estimates pending budget actuals, and NIH RePORT planned to release frozen FY2026 data by December 31, 2026. See the NIH RePORT Data Book and FY2026 data portal for the official reporting resources.
What may explain the FY2025 drop in ESI awards?
NIH said the FY2025 decline in ESI R01-equivalent awardees may partly reflect a policy introduced in June 2025. Under that policy, 50% of remaining competing RPG funds were directed to full-year funded competing awards. NIH expected the approach to result in fewer awards and fewer researchers supported. NIH presented this as a possible contributor, not as a proven sole cause of the ESI decline.
Rank #4
- Used Book in Good Condition
What does the funding outlook mean for current awards?
On September 28, 2026, NIH said the government was operating under a continuing resolution through December 11, 2026, at FY2026 enacted funding levels. Under the notice, NIH institutes and centers may, at their discretion, issue noncompeting research awards below the latest Notice of Award commitment. NIH said upward adjustments would be considered after FY2027 appropriations. Awardees should check their own latest Notice of Award and contact the relevant NIH institute or center for award-specific guidance; the NIH continuing-resolution notice describes the policy context.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Separately, NIH’s FY2027 budget overview proposes fully funding competing RPG outyear commitments at initial obligation. That is a budget proposal and stated policy rationale, not an enacted FY2026 fact. The NIH Office of Budget FY2027 overview says the transition could make more RPG funds available for new projects as legacy noncompeting awards phase out.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Are NIH K awards changing?
Yes. NIH’s August 12, 2026 notice describes planned changes to career-development (K) award programs. The changes are scheduled to begin with due dates on or after October 12, 2027; current affected activity-code opportunities are to expire by July 13, 2027.
- Consolidate individual K funding opportunity notices.
- Remove the data-management-and-sharing-plan requirement for K applications.
- Clarify which clinical-trial activities K funds may support.
K award funds may not be used to conduct a clinical trial, feasibility study, or ancillary study. K awardees may participate in a trial led by a mentor, but a K awardee who wants to lead a trial as principal investigator must obtain separate funding. Applicants should consult NIH’s K-award update notice and the relevant current opportunity for operational details.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
